We were saddened to learn that Susan Solomon, CEO and co‑founder of the New York Stem Cell Foundation, has died. As CEO, she raised more than $400 million for stem cell research, helping catalyze the field and shape the future of medical science.

The foundation announced her passing after a long battle with ovarian cancer.

CIRM Chair Jonathan Thomas said she will be greatly missed. “We were terribly sorry to hear about Susan’s passing. She was a titan in our field who did immeasurable good for patients everywhere. We have deeply valued our relationship with her and NYSCF through the years.”

Like many patient advocates, Solomon became active after disease struck her family. In 1992, her ten‑year‑old son Ben was diagnosed with type 1 diabetes. A lawyer and longtime business executive, she used her skills to seek the best way to help him. In a Wall Street Journal interview, she said her background helped: “As a lawyer, you learn how to learn about a new field instantly,” adding, “I’m really comfortable asking dumb questions.”

After extensive research and conversations with scientists, she concluded that stem cells held the greatest promise. In 2005, she co‑founded NYSCF.

Dr. Jeanne Loring of Scripps Research said Solomon’s death is a major loss: “Susan was one in a billion. She put her considerable energy into starting and sustaining the only stand‑alone research institute in the U.S. dedicated to stem cell research.”